Peripheral Artery Disease (PAD)Peripheral Artery Disease (PAD)
有病率: 8.5 million US adults; 12-20% of adults >60 years
About
Reproducible calf pain that begins at a predictable walking distance and settles within minutes of stopping is the classic presentation of peripheral artery disease, and the reproducibility is what distinguishes it from other causes of leg pain. The condition affects about 8.5 million US adults and between 12 and 20 percent of adults over 60. A substantial share of those affected report no claudication at all, either because activity has been curtailed to stay below the threshold or because coexisting neuropathy blunts the sensation.
The underlying process is atherosclerosis in the arteries supplying the limbs, most often the femoral, popliteal and tibial vessels. At rest, a narrowed artery can still deliver enough blood to meet metabolic demand. Under exertion, demand rises several-fold and the fixed narrowing becomes limiting, so oxygen supply falls short of consumption in the working muscle and anaerobic metabolites accumulate until the muscle is rested. That supply-demand mismatch explains why the symptom is exercise-dependent and why the walking distance at which it appears is stable enough to be measured.
Smoking is the strongest of the recognised risk factors for this condition specifically, more so than for coronary disease, and it acts through endothelial injury, augmented platelet reactivity and vasoconstriction at once. Diabetes is the second dominant contributor and shifts the anatomical pattern toward the smaller vessels below the knee, which are less amenable to revascularisation. Hypertension, dyslipidaemia, age beyond 50 and chronic kidney disease complete the list.
The reason this condition matters beyond the limb is that it functions as a marker of arterial disease elsewhere. Someone with narrowing in the leg arteries is likely to have it in the coronary and carotid circulations too, and the excess mortality associated with PAD is largely cardiovascular rather than limb-related. This is why the recognised management is systemic rather than local, and why supervised exercise therapy holds an unusual position: walking to the point of claudication, repeatedly, improves walking distance through collateral development and metabolic adaptation in the muscle, making it one of the few interventions where the provoking activity is also the intervention.
Cold legs and feet, non-healing wounds, reduced pulses and leg weakness are the remaining listed signs. A non-healing wound below the knee in someone with diabetes is a finding that warrants prompt assessment, since impaired perfusion and impaired sensation compound each other and the interval before tissue loss can be short.
No ingredient currently carries an evidence grade against this endpoint in the collection, and no research paper is linked to it. That absence should be read plainly: it reflects what has been catalogued here, and the graded cardiovascular evidence that does exist has been assembled against the mechanisms underlying PAD rather than against the diagnosis itself, among them atherosclerosis, endothelial dysfunction, high cholesterol and high blood pressure.
Common Symptoms
Risk Factors
- Smoking (strongest risk factor)
- Diabetes
- Hypertension
- Dyslipidemia
- Age >50
- Chronic kidney disease
Frequently Asked Questions
How is the evidence for Peripheral Artery Disease (PAD) supplements graded?
What are common symptoms of Peripheral Artery Disease (PAD)?
FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。